Skip to content

Standex International SXI Scientific Group — Total Costs & Expenses

Similar metrics at other companies

Eos Energy Enterprises, Inc. logo
EOSETotal costs & expenses
$34.89M+22.9%
Adaptive Biotechnologies logo
ADPTTotal costs & expenses
$90.08M+9.8%
Acadia Pharmaceuticals logo
ACADTotal costs & expenses
$272.68M+21.2%
Rhythm Pharmaceuticals, Inc. logo
RYTMTotal costs & expenses
$112.47M+41.1%
GRAIL, Inc. logo
GRALReportable Segment — Total Costs & Expenses
$176.55M-4.8%
Avery Dennison logo
AVYMaterials Group — Segment expense
$1.4B+11.6%

Other financials

Income statement

See full
Revenue$224.6M+8.1%
Net income$68.5M+201%

Balance sheet

See full
Cash & equivalents$103.7M-5.5%
Total debt$521.9M-16.6%
Total equity$754.2M+9.8%
Total assets$1.5B-1.8%

Cash flow

See full
Operating cash flow$11.7M+23.1%
CapEx$5.6M-7.9%
Free cash flow$6.2M+77.5%

Valuation

See full
Market cap$3.83B+60.8%

Profitability

See full
Net margin3.2%
FCF margin7.5%

Returns & leverage

See full
Return on equity16.7%+7.3pp
Debt / equity0.7×-0.2×
Current ratio-0.4×

Where this comes from

Reported directly by Standex International in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The official record: Standex International’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Standex International's scientific group — total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Standex International's scientific group — total costs & expenses?
Standex International (SXI) reported scientific group — total costs & expenses of $14.27M in Q1 2026.
How has Standex International's scientific group — total costs & expenses changed year-over-year?
Standex International's scientific group — total costs & expenses decreased by 0.9% year-over-year, from $14.4M to $14.27M.
What does scientific group — total costs & expenses mean?
The aggregate of all operating costs, including cost of goods sold, research and development, and selling, general, and administrative expenses incurred by the Scientific Group. Monitoring this metric is essential for evaluating the segment's operational cost structure and margin management.